Welcome to LookChem.com Sign In|Join Free
  • or
4-nitro-N-(pyridin-2-ylmethyl)aniline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

408365-67-3

Post Buying Request

408365-67-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

408365-67-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 408365-67-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,8,3,6 and 5 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 408365-67:
(8*4)+(7*0)+(6*8)+(5*3)+(4*6)+(3*5)+(2*6)+(1*7)=153
153 % 10 = 3
So 408365-67-3 is a valid CAS Registry Number.

408365-67-3Relevant academic research and scientific papers

FORMULATION FOR ENHANCED TRANSDERMAL ABSORPTION OF DRUG

-

Paragraph 0047-0048, (2019/04/14)

Provided is a transdermal formulation including a transdermal absorption enhancer including an aliphatic hydrocarbon derivative and a pyrrolidone derivative; and a benzene diamine derivative for preventing or treating dementia, Alzheimer's disease, and ha

COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS INCLUDING BENZENE DIAMINE DERIVATIVE

-

Paragraph 0057-0059, (2019/04/14)

Provided are a compound represented by the following Formula I, or a solvate, stereoisomer, or pharmaceutically acceptable salt thereof, and a composition for preventing or treating hair loss, the compound including the compound as an active ingredient:

COMPOSITION INCLUDING BENZENE DIAMINE DERIVATIVE FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES

-

Paragraph 0081; 0082, (2019/04/14)

Provided are a compound represented by the following Formula I-1 or I-2, and a composition for preventing or treating dementia or Alzheimer's disease, the composition including the compound and a pharmaceutically acceptable carrier:

Discovery, synthesis, and structure-activity relationship development of a series of N -4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4

Jones, Carrie K.,Engers, Darren W.,Thompson, Analisa D.,Field, Julie R.,Blobaum, Anna L.,Lindsley, Stacey R.,Zhou, Ya,Gogliotti, Rocco D.,Jadhav, Satyawan,Zamorano, Rocio,Bogenpohl, Jim,Smith, Yoland,Morrison, Ryan,Daniels, J. Scott,Weaver, C. David,Conn, P. Jeffrey,Lindsley, Craig W.,Niswender, Colleen M.,Hopkins, Corey R.

supporting information; experimental part, p. 7639 - 7647 (2012/01/05)

There is an increasing amount of literature data showing the positive effects on preclinical antiparkinsonian rodent models with selective positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu4). However, most of the data ge

SUBSTITUTED 1,1,3,3-TETRAOXIDOBENZO[D][1,3,2]DITHIAZOLES AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION

-

Page/Page column 108, (2010/08/09)

Compounds useful as allosteric potentiators/positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4) and methods of using the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 408365-67-3